Bg pattern

EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Ebastina Sandoz 10 mg orodispersible tablets EFG

Ebastina Sandoz 20 mg orodispersible tablets EFG

Read this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Ebastina Sandoz is and what it is used for
  2. What you need to know before you take Ebastina Sandoz
  3. How to take Ebastina Sandoz
  4. Possible side effects
  5. Storage of Ebastina Sandoz
  6. Contents of the pack and other information

1. What Ebastina Sandoz is and what it is used for

Ebastina is an antihistamine that helps to relieve the symptoms of allergy such as: sneezing, runny nose, tearful eyes, itchy skin rashes.

Ebastina is used in adults and children over 12 years of age to relieve the symptoms of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis, including cases with allergic conjunctivitis.

Ebastina 10 mg tablets are also used in adults over 18 years of age to relieve the symptoms of itching and hives in cases of urticaria (hives).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Ebastina Sandoz

Do not take Ebastina Sandoz:

  • If you are allergic to ebastina or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Ebastina Sandoz if:

  • you are already taking certain antibiotics or medicines used to treat fungal infections: see section "Taking Ebastina Sandoz with other medicines"later,
  • you have severely impaired liver function (liver failure).

Children and adolescents

This medicine should only be used in children over 12 years of age. Do not give this medicine to children under 12 years of age as the safety and efficacy in this age group have not been established.

Taking Ebastina Sandoz with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you take ebastina with erythromycin (an antibiotic), ketoconazole or itraconazole (active substances for the treatment of fungal infections), it may increase the levels of ebastina in your blood.

Taking ebastina and rifampicin (an antitubercular agent) together may lead to a decrease in the levels of ebastina in your blood and therefore a decrease in its effect.

It is not recommended to use ebastina at the same time as clarithromycin or josamycin (antibiotics).

Taking Ebastina Sandoz with food and drink

Ebastina Sandoz can be taken with or without food.

Pregnancy, breastfeeding and fertility

There are no sufficient data on the safety of this medicine in human pregnancy. For this reason, ebastina should only be taken during pregnancy if your doctor considers that the benefit outweighs the potential risks.

Do not take ebastina if you are breastfeeding, as it is not known whether the active substance is excreted in breast milk.

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Most patients taking ebastina can drive or perform other activities that require attention. However, as with other medicines, you should check your individual reaction after taking ebastina before driving or performing complex activities, as some patients may experience drowsiness or dizziness.

Ebastina Sandoz contains lactose, aspartame and sodium.

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

This medicine contains 2.5 mg of aspartame (E951) per 10 mg tablet and 5 mg of aspartame (E951) per 20 mg tablet. Aspartame is a source of phenylalanine, which may be harmful if you have phenylketonuria (a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly).

This medicine contains less than 23 mg of sodium (1 mmol) per orodispersible tablet, which is essentially "sodium-free".

3. How to take Ebastina Sandoz

Follow exactly the instructions of your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.

The recommended dose is:

Indication

Age

Dose

Allergic rhinitis

In case of intense symptoms

Children over 12 years of age and adults

One 10 mg ebastina tablet (10 mg of ebastina) once a day.

Two 10 mg ebastina tablets or one 20 mg ebastina tablet (20 mg of ebastina) once a day.

Urticaria

Adults over 18 years of age

One 10 mg ebastina tablet (10 mg of ebastina) once a day.

In patients with impaired renal function, no dose adjustment is necessary.

In patients with mild or moderate liver impairment, no dose adjustment is necessary.

There is no experience with doses greater than 10 mg in patients with severe liver failure, therefore the dose should not exceed 10 mg in these patients.

Do not press the tablet to remove it from the blister, as it may break.

Each blister contains the tablets separately in separate alveoli separated by a perforation line.

Cut one of the alveoli along the dotted line (Figure 1)

Hand applying a medicinal patch to the skin with a black arrow indicating the direction of application and the number one

Then, carefully remove the aluminum foil, separating it at the corner indicated by an arrow (Figures 2 and 3).

Two fingers holding a device with a button and a black arrow indicating the direction to pressHands holding a white rectangular device with a black arrow pointing upwards number three down

Keep your hands dry to remove the tablet from the alveolus.

Place your tablet on your tongue where it dissolves in a matter of seconds, you do not need to take water or any other liquid.

Ebastina can be taken with or without food.

Your doctor will indicate the duration of the treatment.

If you take more Ebastina Sandoz than you should

There is no specific antidote for the active substance ebastina.

In case of overdose with ebastina, please consult your doctor. Depending on the severity of the poisoning, your doctor will initiate the necessary measures (monitoring of vital functions, including ECG monitoring for at least 24 hours, symptomatic treatment, and gastric lavage) if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Ebastina Sandoz

Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Ebastina Sandoz and contact your doctor immediately or go to the nearest hospital if you experience:

Severe allergic reaction that causes itching and swelling of the face, tongue, or throat and may cause difficulty swallowing or breathing.

Severe allergic reactions with ebastina are rare (may affect up to 1 in 1000 people).

Other side effects include:

Very common side effectsmay affect more than 1 in 10 people

  • headache.

Common side effectsmay affect up to 1 in 10 people

  • drowsiness
  • dry mouth.

Rare side effectsmay affect up to 1 in 1,000 people

  • nervousness, insomnia,
  • dizziness, decreased sense of touch, altered taste,
  • palpitations, rapid pulse,
  • abdominal pain, vomiting, nausea, indigestion,
  • liver inflammation (hepatitis), bile elimination problems (cholestasis), abnormal liver function tests,
  • skin rash, hives, skin inflammation,
  • menstrual disorders,
  • edema (swelling due to fluid accumulation in tissues), weakness (asthenia).

Frequency not known: cannot be estimated from the available data

  • weight gain,
  • increased appetite.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ebastina Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date is the last day of the month stated.

Store in the original package to protect from light.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Ebastina Sandoz

  • The active substance is ebastina.
    • Ebastina Sandoz 10 mg: each orodispersible tablet contains 10 mg of ebastina.
    • Ebastina Sandoz 20 mg: each orodispersible tablet contains 20 mg of ebastina.
  • The other ingredients are microcrystalline cellulose, lactose monohydrate, corn starch, sodium croscarmellose, aspartame (E951), peppermint flavor, colloidal anhydrous silica, and magnesium stearate.

Appearance and packaging

Orodispersible tablet.

Ebastina Sandoz 10 mg:

White, biconvex, round tablets, approximately 6.7 mm in diameter, marked with "E10" on one face and smooth on the other face.

Ebastina Sandoz 20 mg:

White, biconvex, round tablets, approximately 9.2 mm in diameter, marked with "E20" on one face and smooth on the other face.

The tablets are packaged in OPA/Alu/PVC/Alu blisters packaged in cartons.

Package sizes:

Ebastina Sandoz 10 mg:

10, 20, 30, 40, 50, 90, 98, or 100 orodispersible tablets.

Ebastina Sandoz 20 mg:

10, 15, 20, 30, 40, 50, 98, or 100 orodispersible tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Sandoz Farmacéutica, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Lek Pharmaceuticals d.d.

Verovškova 57,

1526 Ljubljana

Slovenia

TEVA Pharmaceutical Works Private Limited Company

Pallagi út 13, 4042 Debrecen

Hungary

or

Teva Pharma, S.L.U.

C/Anabel Segura 11, Edificio Albatros B, 1st floor, Alcobendas, 28108

Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Belgium:Ebastine Sandoz 10 mg orodispersible tablets

Italy:Ebastina Sandoz

Sweden:Ebastine Sandoz, 10 mg orodispersible tablets

Ebastine Sandoz, 20 mg orodispersible tablets

Date of last revision of this leaflet:August 2020

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS

Discuss questions about EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS?
EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS?
The active ingredient in EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS is ebastine. This information helps identify medicines with the same composition but different brand names.
How much does EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS cost in pharmacies?
The average pharmacy price for EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS is around 8.79 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS?
EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS is manufactured by Sandoz Farmaceutica S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EBASTINE SANDOZ 20 mg ORALLY DISINTEGRATING TABLETS?
Other medicines with the same active substance (ebastine) include BACTIL 10 mg FILM-COATED TABLETS, BACTIL FLAS 10 mg ORAL LYOPHILIZED, BACTIL FORTE 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media